AIM
ONC

Anchor Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Anchor Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.1K Hold
108
– – ﹤0.01% 662
2025
Q4 		$32.8K Hold
108
– – ﹤0.01% 661
2025
Q3 		$36.8K Hold
108
– – ﹤0.01% 634
2025
Q2 		$26.1K Hold
108
– – ﹤0.01% 683
2025
Q1 		$29.4K Hold
108
– – ﹤0.01% 654
2024
Q4 		$19.9K Hold
108
– – ﹤0.01% 712
2024
Q3 		$24.2K Buy
+108
New +$19.4K ﹤0.01% 673

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Anchor Investment Management's ONC Position: Q1 2026 in Review

Anchor Investment Management held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 108 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Anchor Investment Management first reported a position in ONC in Q3 2024 and has held it in 7 quarters since. The position peaked at $36.8K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Anchor Investment Management held 108 shares of BeOne Medicines Ltd worth $32.1K as of Q1 2026.
  • Anchor Investment Management left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #662 holding.
  • Anchor Investment Management first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 7 quarters since.
  • Anchor Investment Management's BeOne Medicines Ltd position peaked at $36.8K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.